GDF-15 may be a predictor of incidence of CKD, eGFR decline (36) and CVD independent of traditional CV risk factors, renal function, and other biomarkers (C-reactive protein, B-type natriuretic peptide, cardiac troponin) (37). This evidence concerns the gene CRP and chronic kidney disease.